Primary ciliary dyskinesia (PCD) is a rare inherited condition in which the tiny hair-like structures lining the airways, sinuses, ears, and other organs do not beat properly, leaving the body unable to clear mucus the way it normally would. Because those same structures play roles in organ placement during embryonic development and in reproductive function, the disease reaches well beyond the lungs. Mutations in any of more than 50 different genes can cause PCD, which helps explain why symptoms vary so widely from person to person and why diagnosis is often delayed by years or even decades.
What Causes PCD at the Genetic Level
PCD is the only known genetic disorder of motile cilia dysfunction, yet it is not a single-gene disease. Instead, a mutation in any one of dozens of genes that encode parts of the cilia’s internal machinery can produce a similar set of problems. In the vast majority of cases the inheritance pattern is autosomal recessive, meaning a child must receive a faulty copy of the same gene from each parent to develop the condition.1PubMed Central. Genetics and biology of primary ciliary dyskinesia Rare autosomal dominant and X-linked patterns have also been described, though they account for a small fraction of cases.2PubMed Central. Primary ciliary dyskinesia: a case report of double DNAH11 mutant alleles
The genes involved encode proteins that make up different parts of the cilium’s internal scaffold, called the axoneme. Some of the most commonly affected genes, such as DNAH5 and DNAI1, code for components of the outer dynein arms, the molecular motors that power the beating stroke of each cilium. Others affect inner dynein arms, radial spokes, or the assembly machinery that builds cilia inside the cell. The specific gene that is mutated influences which structural piece is missing or malformed, and that in turn shapes the severity and pattern of symptoms. Diagnosis traditionally relies on identifying these structural abnormalities, particularly defects in the outer and inner dynein arms.3PubMed. Ciliary defects and genetics of primary ciliary dyskinesia
Why Broken Cilia Cause So Many Problems
Motile cilia line the airways from the nose down to the small bronchi, and they also appear in the middle ear, the sinuses, the reproductive tract, and the fluid-filled ventricles of the brain. In healthy people, these cilia beat in coordinated waves that push mucus, trapped particles, and pathogens upward and out of the lungs. When cilia are immotile or beat in an uncoordinated way, mucus stagnates. Bacteria settle in and trigger chronic infections. The result is a cycle of infection and inflammation that, over years, damages airway walls and leads to bronchiectasis, a permanent widening and scarring of the bronchial tubes.
The same clearance problem plays out in the sinuses and middle ears, which is why nearly every person with PCD has chronic sinus disease and many have recurrent ear infections from early childhood. The effects on other organ systems stem from distinct functions of cilia in those tissues, discussed in the sections below.
Symptoms in Newborns
One of the earliest red flags for PCD is unexplained breathing difficulty right after birth. More than 80% of babies who are eventually diagnosed with PCD experience neonatal respiratory distress, often requiring supplemental oxygen for days or weeks because mucus plugs their small airways and causes areas of lung collapse.4PubMed Central. Respiratory Distress in the Newborn with Primary Ciliary Dyskinesia In a large study of 455 participants, about two-thirds reported a history of neonatal respiratory distress, and the likelihood varied by genotype: those with DNAH11 mutations were significantly less likely to have had breathing trouble at birth, while those with certain loss-of-function variants in DNAH5 were more likely.5PubMed Central. The Association of Neonatal Respiratory Distress With Ciliary Ultrastructure and Genotype in Primary Ciliary Dyskinesia
This matters because a newborn who breathes well may not be flagged for PCD evaluation, yet the absence of neonatal distress does not rule the disease out. Clinicians are now advised to maintain a high level of suspicion for PCD even in babies who had an uneventful first few days, particularly if other suggestive features are present, such as an unusual arrangement of internal organs.
Chronic Lung Disease and Bronchiectasis
After the neonatal period, lung problems settle into a chronic pattern. Children develop a persistent wet cough, frequent lower respiratory infections, and recurrent pneumonias, often in the same lung segments. Over time, this cycle of infection and inflammation leads to bronchiectasis. In adults, PCD-related bronchiectasis tends to involve the middle and lower lobes of both lungs, and it usually shows up alongside chronic rhinosinusitis with or without nasal polyps. A large registry study found that the combination of sinus disease, bronchiectasis present for more than 15 years, involvement of any middle and lower lobe, age under 53, and a history of Pseudomonas infection in the airways together strongly predicted that PCD was the underlying cause of a patient’s bronchiectasis.6PubMed Central. Primary Ciliary Dyskinesia in Adult Bronchiectasis: Data from the German Bronchiectasis Registry PROGNOSIS
Pseudomonas colonization is an especially important marker. Once that bacterium establishes itself in the airways, it is difficult to eradicate and tends to accelerate lung damage. Identifying PCD as the reason behind recurrent infections matters because it changes how aggressively airway clearance and antibiotics are pursued.
Ear, Nose, and Sinus Involvement
Ear and sinus problems are nearly universal in PCD and often precede the lung complications that eventually trigger a formal diagnosis. Across multiple studies, roughly 60% of children with PCD have a documented history of middle-ear infections, and about 39% have some degree of hearing loss, most of it conductive, meaning it results from fluid or scarring in the middle ear rather than nerve damage.7Sinusitis. Otologic and Sinonasal Manifestations of Pediatric Primary Ciliary Dyskinesia: A Scoping Review Tympanostomy tubes, the tiny tubes surgeons place in the eardrum to drain fluid, are used in more than half of PCD patients, and many require multiple sets over the years.
In a study of nearly 400 individuals with PCD, about half reported ear pain, about a third reported ear discharge, and close to half reported hearing problems. Hearing impairment, usually mild, became more common with age: adults over 40 were roughly three times more likely to have hearing loss than children under 10.8JAMA Otolaryngology–Head & Neck Surgery. Characteristics of Otologic Disease Among Patients With Primary Ciliary Dyskinesia The sinuses are affected in about four out of five children with PCD, with chronic rhinosinusitis and a constantly runny or congested nose being the dominant complaints.7Sinusitis. Otologic and Sinonasal Manifestations of Pediatric Primary Ciliary Dyskinesia: A Scoping Review
For adults, conductive hearing loss remains the most frequent type, affecting roughly a quarter of PCD patients in one controlled study compared to about 12% of matched controls.9PubMed Central. Otological Manifestations in Adults with Primary Ciliary Dyskinesia: A Controlled Radio-Clinical Study These ear and sinus symptoms often lead children to an ear, nose, and throat specialist long before anyone suspects PCD, which is one reason the diagnosis is so frequently delayed.
Organ Laterality and Situs Inversus
Roughly half of people with PCD have situs inversus totalis, meaning all of their internal organs are mirror-reversed: the heart sits on the right, the liver on the left, and so on. The combination of situs inversus, bronchiectasis, and chronic sinusitis was historically called Kartagener syndrome, the clinical picture that first drew attention to PCD in the mid-twentieth century.
The reason for the organ reversal traces back to embryonic development. Early in gestation, a specialized group of cells at a structure called the embryonic node carries rotating cilia. These cilia create a tiny leftward flow of fluid that sets off a cascade of molecular signals determining which side of the body becomes “left” and which becomes “right.” When those cilia cannot rotate properly, the flow never forms, and laterality is essentially a coin flip. Some PCD patients end up with normal organ placement (situs solitus), some with complete reversal, and a small fraction end up with a mix, called situs ambiguus or heterotaxy, which can be associated with complex congenital heart defects.10The American Journal of Human Genetics. Axonemal Dynein Intermediate-Chain Gene (DNAI1) Mutations Result in Situs Inversus and Primary Ciliary Dyskinesia (Kartagener Syndrome)
A mouse model of PCD caused by mutations in the Dnahc5 gene illustrates the spectrum: homozygous animals develop heterotaxy and complex heart defects, and many also develop hydrocephalus because ependymal cilia in the brain’s ventricles fail to circulate cerebrospinal fluid properly.11JCI Insight. Heterotaxy and complex structural heart defects in a mutant mouse model of primary ciliary dyskinesia Hydrocephalus is uncommon in human PCD patients but has been reported, underscoring that cilia dysfunction can occasionally reach beyond the lungs, sinuses, and ears.12PubMed Central. Ependymal ciliary motion and their role in congenital hydrocephalus
Fertility Effects in Men and Women
Cilia and cilia-like structures are essential for reproduction in both sexes. In men, sperm tails share the same core architecture as motile cilia. When the axonemal proteins are abnormal, sperm often cannot swim effectively, and the efferent ductules of the testis, which rely on ciliated cells to transport sperm, may also function poorly. The result is reduced sperm counts and motility, and many men with PCD meet the clinical definition of subfertility or infertility.13PubMed Central. The impact of primary ciliary dyskinesia on female and male fertility: a narrative review
In women, the fallopian tubes are lined with ciliated cells that beat in a coordinated wave toward the uterus, helping move the egg and early embryo. If those cilia do not work properly, transport is impaired, which can reduce the chances of fertilization and implantation. Women with PCD can and do conceive naturally, but the rate of subfertility appears higher than in the general population. Assisted reproductive technologies such as in vitro fertilization bypass much of this barrier for both sexes.13PubMed Central. The impact of primary ciliary dyskinesia on female and male fertility: a narrative review
How PCD Is Diagnosed
Diagnosis of PCD is notoriously difficult, partly because no single test is definitive on its own and partly because the symptoms overlap with other common childhood conditions like asthma and recurrent colds. The average delay between symptom onset and diagnosis stretches well into adulthood for many patients.
Nasal nitric oxide (nNO) measurement has become a first-line screening tool. People with PCD produce extremely low levels of nitric oxide in their nasal passages, for reasons that are still not entirely understood. In cooperative patients, generally aged five and older, an nNO test has a sensitivity around 97% and specificity around 96%, making it a strong initial screen when clinical suspicion is already high and cystic fibrosis has been excluded.14PubMed Central. Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia. A Technical Paper on Standardized Testing Protocols15Annals of the American Thoracic Society. Accuracy of Nasal Nitric Oxide Measurement as a Diagnostic Test for Primary Ciliary Dyskinesia. A Systematic Review and Meta-analysis
A low nNO result typically triggers further investigation. The standard confirmatory approach in many centers combines high-speed video microscopy of ciliary beating with transmission electron microscopy of ciliary ultrastructure, looking for missing or shortened dynein arms, disorganized microtubules, or other structural defects. However, the equipment and expertise for these analyses are not widely available worldwide.16PubMed Central. Accuracy of Immunofluorescence in the Diagnosis of Primary Ciliary Dyskinesia Genetic testing can confirm the diagnosis when two disease-causing mutations are found in a known PCD gene, and it is increasingly used as a standalone confirmatory method in centers where electron microscopy is unavailable.
Treatment: Airway Clearance and Antibiotics
There is currently no cure for PCD. Treatment focuses on compensating for the body’s inability to clear mucus on its own and on aggressively treating the infections that inevitably follow. Airway clearance therapy is the backbone of daily management. Common techniques include breathing exercises like the active cycle of breathing technique, devices that create positive expiratory pressure to help keep airways open, postural drainage, and chest physiotherapy. Comparative studies have not shown that any single technique is clearly superior to the others, so the choice often comes down to what the patient can stick with consistently.17PubMed Central. Physiotherapy in Primary Ciliary Dyskinesia-What Is the Evidence?: A Narrative Review and Personal Experience
On the medication side, clinical guidelines center on antibiotics and airway clearance, but in practice many patients also use bronchodilators, inhaled corticosteroids, and nebulized mucolytic agents like hypertonic saline, often borrowed from cystic fibrosis treatment protocols, despite limited evidence that these extra treatments help in PCD specifically.18PubMed. Treatment of Lung Disease in Primary Ciliary Dyskinesia: A Review of Current and Emerging Interventions Prophylactic low-dose azithromycin, taken regularly rather than just during flare-ups, has shown promise: one study found the average number of lung exacerbations dropped from about 1.7 per year to 0.5 per year, and sinus symptoms improved as well, though lung function decline was not slowed.19European Respiratory Journal. Prophylactic azithromycin in patients with primary ciliary dyskinesia
Surgery for Ear and Sinus Disease
The role of surgery in PCD is focused mainly on the ears and sinuses, where medical management alone often falls short. Ear tube placement for persistent middle-ear fluid has historically been controversial in PCD because up to half of these children develop ear discharge (otorrhea) after tube insertion. But more recent data suggest the problem is manageable: in a multicenter study, about 23% of PCD patients who received tubes had chronic or recurrent discharge, and most episodes were controlled with antibiotic ear drops. Researchers have argued that tubes should be discussed as a standard option rather than routinely avoided.20PubMed Central. Otolaryngology Manifestations of Primary Ciliary Dyskinesia: A Multicenter Study
Endoscopic sinus surgery for adults with chronic rhinosinusitis from PCD appears effective. Patients show significant improvement in symptom scores and endoscopic findings, and that improvement holds over the follow-up period. One exception is smell: olfaction does not seem to recover after surgery, for reasons that remain unclear.21PubMed Central. Outcomes of Endoscopic Sinus Surgery for Chronic Rhinosinusitis in Adults with Primary Ciliary Dyskinesia
Long-Term Lung Function and Prognosis
How lung function changes over a lifetime with PCD varies enormously from person to person. In one long study spanning three decades, about a third of patients lost more than 10 percentage points of their baseline lung capacity, roughly 57% remained stable, and about 10% actually improved. The trajectory did not correlate with how old a patient was when diagnosed or how good their lung function was at the time of diagnosis.22American Journal of Respiratory and Critical Care Medicine. Lung Function in Patients with Primary Ciliary Dyskinesia: A Cross-Sectional and 3-Decade Longitudinal Study An international pediatric cohort found a similar picture: about 39% of children and young adults showed declining lung function, 40% stayed stable, and 21% improved over a median follow-up of about four years.23PubMed Central. Lung Function in Children with Primary Ciliary Dyskinesia
The fact that early diagnosis does not by itself guarantee preservation of lung function is sobering. It strongly suggests that we do not yet fully understand what drives progressive disease in some patients but not others. Still, estimates suggest that somewhere between 38% and 51% of adults with PCD eventually develop severe lung impairment, require supplemental oxygen, or are referred for lung transplantation.24CHEST Pulmonary. Diffuse Lung Disease: CHEST Pulmonary Reviews Primary Ciliary Dyskinesia Lung transplant is feasible even in patients with situs inversus, though the surgery requires careful preoperative imaging and planning because the reversed anatomy creates challenges in matching donor lungs to the recipient’s chest.25PubMed Central. Lung Transplantation for Primary Ciliary Dyskinesia and Kartagener Syndrome: A Multicenter Study
How PCD Compares to Cystic Fibrosis
PCD is sometimes confused with cystic fibrosis because both cause chronic wet cough, recurrent lung infections, and bronchiectasis in young people. Both are inherited, and both involve impaired mucociliary clearance. But the underlying defects are completely different: cystic fibrosis is caused by mutations in a single gene (CFTR) that controls chloride and water transport across cell membranes, leading to abnormally thick, sticky mucus. In PCD the mucus itself is normal; the problem is that the cilia cannot move it. PCD is also considerably rarer than cystic fibrosis, especially among people of European descent.26PubMed. Cystic fibrosis and primary ciliary dyskinesia: Similarities and differences The distinction matters because the treatments are different, and borrowing therapies from one disease for use in the other, as often happens with nebulized mucolytics, does not always work.
Inhaled mRNA Therapy and the Future of Treatment
The most exciting development on the horizon is gene-targeted therapy using messenger RNA delivered directly to the lungs. Because PCD can be caused by dozens of different genes, any gene therapy approach has to be developed gene by gene. Researchers have made the most progress with DNAI1, one of the more commonly mutated genes. In preclinical work, lipid nanoparticles carrying DNAI1 mRNA were aerosolized and delivered to the lungs of mice and nonhuman primates. The mRNA reached multiciliated cells in the lower airways, was translated into functional DNAI1 protein, and in a cell-based PCD model, restored ciliary beating.27PubMed Central. Inhaled DNAI1 mRNA therapy for treatment of primary ciliary dyskinesia28PubMed. Inhaled delivery of a lipid nanoparticle encapsulated messenger RNA encoding a ciliary protein for the treatment of primary ciliary dyskinesia
Work is also underway on CCDC40, another PCD-associated gene. Using a similar lipid nanoparticle approach, investigators showed that delivering CCDC40 mRNA corrected structural and motility defects in human cells and in zebrafish, which share the same basic cilia architecture with humans.29American Journal of Respiratory Cell and Molecular Biology. mRNA therapy improves the composition and motility in CCDC40-deficient cilia in vitro and in vivo The fact that these therapies use mRNA rather than DNA means they do not permanently alter the genome, which is reassuring from a safety standpoint, but it also means repeated dosing would be needed. None of these approaches has entered human clinical trials yet, so they remain years away from the clinic. Still, the proof of concept is real, and for a disease that has had no disease-modifying treatment to date, the trajectory is genuinely encouraging.
Why Model Organisms Matter for PCD Research
One reason PCD research has advanced steadily despite the disease’s rarity is that motile cilia are ancient. The same basic ultrastructure and many of the same proteins appear in organisms as different as single-celled algae, parasitic protists, flatworms, zebrafish, frogs, and mice.30PubMed Central. PCD Genes-From Patients to Model Organisms and Back to Humans That evolutionary conservation means scientists can knock out a candidate PCD gene in a zebrafish or a green alga, observe the effect on cilia, and draw conclusions that translate surprisingly well to human disease. It also means that when new treatments like mRNA therapy are tested in animal models, the results carry genuine relevance. The broad toolkit of model organisms has been critical in identifying new PCD genes and in testing therapeutic concepts before they reach mammalian systems, and it will likely remain central to the field for the foreseeable future.